It's especially difficult to package ovariancancer into a good news story.
2
Background: The immune system strongly influences outcome in patients with ovariancancer.
3
Objective: Epithelial ovariancancer has the highest mortality rate among gynecologic cancers.
4
Purpose: Radiation therapy can provide useful palliation in chemorefractory ovariancancer patients.
5
Objectives: Novel strategies for the treatment of chemoresistant ovariancancer are needed.
1
Objective: To determine the effect of chemotherapy on glucose metabolism in patients with malignantovariantumor.
2
Results: The patients all were misdiagnosed as ovarian carcinoma, and operations designed for malignantovariantumor were performed on all of them.
3
Immunohistochemistry illustrated a significant inverse CtBP2 and BRCA1 expression in a panel of malignantovariantumor tissues.
4
Conclusion: Ovarian metastases from colon cancer show a smooth margin and more cystic nature on CT compared with primary malignantovariantumors.
5
Objective: The computed tomography (CT) findings of ovarian metastases from colon cancer were evaluated and were compared with those of primary malignantovariantumors.
1
Oral contraceptives have been shown to be protective against hereditaryovariancancer.
2
But it has also shown strong evidence of tumor response in patients with hereditaryovariancancer.
3
But it has also shown strong evidence of tumour response in patients with hereditaryovariancancer.
Ús de primary ovarian cancer en anglès
1
Apoptosis was observed in primaryovariancancer cell culture treated with COX-2 inhibitor.
2
Methods: A total of 73 patients with primaryovariancancer were enrolled into this study.
3
Objective: To estimate the association of preoperative CA 125 levels with outcome in primaryovariancancer patients.
4
These data suggest that the presence of EGF receptor mRNA is associated with poor prognosis in primaryovariancancer.
5
Detailed dietary intake information was available from 85 first primaryovariancancer cases and 492 population-based controls.
6
Conclusion: In summary, in patients with primaryovariancancer, overexpression of MRP1 is an adverse marker for patient outcome and cancer aggressiveness.
7
Conclusion: The review indicated that HIPEC-based regimens was correlated with better clinical prognosis for patients with primaryovariancancers.